MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,625,000 | +53.4% | 60,264 | +27.3% | 0.00% | – |
| Q2 2023 | $1,711,000 | -7.5% | 47,354 | -4.8% | 0.00% | -100.0% |
| Q1 2023 | $1,850,000 | +30.3% | 49,762 | +58.7% | 0.00% | – |
| Q4 2022 | $1,420,000 | -23.2% | 31,352 | +18.3% | 0.00% | -100.0% |
| Q3 2022 | $1,850,000 | +13.6% | 26,511 | +9.2% | 0.00% | – |
| Q2 2022 | $1,629,000 | +48.5% | 24,273 | +81.8% | 0.00% | – |
| Q1 2022 | $1,097,000 | -87.3% | 13,353 | -77.3% | 0.00% | -100.0% |
| Q4 2021 | $8,616,000 | +420.6% | 58,745 | +528.0% | 0.00% | – |
| Q3 2021 | $1,655,000 | -53.6% | 9,355 | -57.6% | 0.00% | -100.0% |
| Q2 2021 | $3,565,000 | -54.0% | 22,067 | -51.2% | 0.00% | -50.0% |
| Q1 2021 | $7,752,000 | +4.0% | 45,259 | +33.4% | 0.00% | 0.0% |
| Q4 2020 | $7,453,000 | +36.0% | 33,934 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $5,482,000 | +9.2% | 33,012 | -25.0% | 0.00% | 0.0% |
| Q2 2020 | $5,022,000 | +65.7% | 43,990 | +11.6% | 0.00% | +100.0% |
| Q1 2020 | $3,030,000 | +334.1% | 39,412 | +627.4% | 0.00% | – |
| Q4 2019 | $698,000 | +141.5% | 5,418 | +46.2% | 0.00% | – |
| Q3 2019 | $289,000 | -22.5% | 3,705 | +2.5% | 0.00% | – |
| Q2 2019 | $373,000 | +6.3% | 3,615 | -24.4% | 0.00% | – |
| Q1 2019 | $351,000 | +76.4% | 4,780 | +2.1% | 0.00% | – |
| Q4 2018 | $199,000 | -23.2% | 4,683 | -15.2% | 0.00% | – |
| Q3 2018 | $259,000 | +12850.0% | 5,520 | +5475.8% | 0.00% | – |
| Q4 2017 | $2,000 | – | 99 | -4.8% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 104 | -80.2% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 524 | -38.7% | 0.00% | – |
| Q4 2016 | $4,000 | -76.5% | 855 | -66.0% | 0.00% | – |
| Q3 2016 | $17,000 | -41.4% | 2,516 | -53.4% | 0.00% | – |
| Q2 2016 | $29,000 | -93.0% | 5,400 | -71.9% | 0.00% | – |
| Q1 2016 | $412,000 | -15.4% | 19,250 | +24.8% | 0.00% | – |
| Q4 2015 | $487,000 | +20.5% | 15,422 | +31.4% | 0.00% | – |
| Q3 2015 | $404,000 | -28.2% | 11,738 | -34.4% | 0.00% | – |
| Q2 2015 | $563,000 | +8.3% | 17,899 | +0.8% | 0.00% | – |
| Q1 2015 | $520,000 | +62.0% | 17,752 | +2.3% | 0.00% | – |
| Q4 2014 | $321,000 | +92.2% | 17,361 | +82.7% | 0.00% | – |
| Q3 2014 | $167,000 | -7.2% | 9,502 | +5.6% | 0.00% | – |
| Q2 2014 | $180,000 | -4.8% | 9,002 | -9.1% | 0.00% | – |
| Q1 2014 | $189,000 | -54.0% | 9,902 | -59.9% | 0.00% | – |
| Q4 2013 | $411,000 | +15.4% | 24,723 | +5.1% | 0.00% | – |
| Q3 2013 | $356,000 | – | 23,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |